Result highlights:
- Key CY21 results have outperformed the prospectus forecast
- CY22 prospectus forecast reaffirmed
- CY21 dividend payout of 75% of Proforma NPATA1 , 1.47 cents per share, fully-franked
- Continued strong safety focus; achieving a 28% reduction in TRIFR2
- Total revenue stable at $4.6 billion, demonstrating resilience through 2021
- Work in hand increased to $16.8 billion, up 28% from CY20
- Statutory EBITDA of $312.2 million and Statutory NPAT of $19.5 million3
- Strong pro forma EBITDA of $379.9 million, up 7.2% at a margin of 8.3%
- Diligent cash focus delivered pro forma Operating cash flow conversion of 84.9%4